C3.ai Executive Chairman Thomas Siebel Sells $7.06M in Stock via Pre-Planned 10b5-1 Plan
AI is trading near its 52-week low of $12.59 (4.1% above the low).
Summary
C3.ai's Executive Chairman, Thomas M. Siebel, sold over $7 million worth of Class A Common Stock through a pre-arranged 10b5-1 trading plan, following an option exercise.
Key Events · Ownership and Investor Activity · AI
-
Executive Chairman Sells Shares
Thomas M. Siebel, Executive Chairman, Director, and 10% Owner, sold 522,175 shares of Class A Common Stock.
-
Significant Transaction Value
The total value of the open market sales amounted to $7,059,806.
-
Pre-Planned Sale
The transaction was executed pursuant to a Rule 10b5-1 trading plan established in September 2024.
-
Option Exercise Preceded Sale
The sale followed the exercise of options to acquire 212,586 shares at a lower strike price of $2.04.
Analysis · AI · Technology
The sale of over $7 million in C3.ai stock by Executive Chairman Thomas M. Siebel, a significant transaction for the company, is a negative signal. Although executed under a pre-planned 10b5-1 trading plan, which mitigates the immediate discretionary implications, it still represents a reduction in direct insider ownership by a key executive. The timing, while pre-arranged, occurs as the stock trades near its 52-week low, which could be viewed as a missed opportunity to demonstrate conviction in a recovery. Investors should consider this reduction in insider stake alongside other company fundamentals.
How filings like this one have moved
In the 30 days to Sep 11, 2026, 30.5% of the 1993 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.21%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AI was trading at $13.10 on NYSE in the Technology sector, with a market capitalization of approximately $1.8B. The 52-week trading range was $12.59 to $35.98. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.